Rotaviruses and rotavirus vaccines

British Medical Bulletin

Volumn 90, Issue 1, 2009, Pages 37-51

  Desselberger, Ulrich ^a   Manktelow, Emily ^a   Li, Wilson ^a   Cheung, Winsome ^a   Iturriza Gómara, Miren ^b   Gray, Jim ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Correlates of protection; Rotavirus; Rotavirus epidemiology; Rotavirus pathogenesis; Rotavirus replication; Rotavirus vaccines

Indexed keywords

IMMUNOGLOBULIN; LIVE VACCINE; PLACEBO; ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE; VIRUS RNA;

CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; FUNDING; GASTROENTERITIS; GENOME; HOST CELL; HUMAN; IMMUNE RESPONSE; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; ORAL REHYDRATION THERAPY; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; ROTAVIRUS; ROUGH ENDOPLASMIC RETICULUM; VIRUS ATTACHMENT; VIRUS CLASSIFICATION; VIRUS GENOME; VIRUS INFECTION; VIRUS MORPHOGENESIS; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; DEVELOPING COUNTRY; DRUG DESIGN; FEMALE; GENETICS; INFANT; MALE; PRESCHOOL CHILD; VIROLOGY;

CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG DESIGN; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VIRUS REPLICATION;

EID: 66749140654     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldp009     Document Type: Review

References (54)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis, 9, 565-572
2. Parashar UD, Gibson CJ, Bresee JS, Glass RI (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis, 12, 304-306
3. Estes MK, Kapikian AZ (2007) Rotaviruses. In Knipe DM, Howley PM et al. (eds) Fields Virology, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 1917-1974
4. Maunula L, von Bonsdorff CH (2002) Frequent reassortments may explain the genetic heterogeneity of rotaviruses: analysis of Finnish rotavirus strains. J Virol, 76, 11793-11800
5. Matthijnssens J, Ciarlet M, Heiman E et al. (2008) Full genome-based classification of rota-viruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol, 82, 3204-3219
6. Ló pez S, Arias CF (2004) Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol 12; 271-278 Review.
7. Desselberger U (1996) Genome rearrangements of rotaviruses. Adv Virus Res, 46, 69-95. Review.
8. Komoto S, Sasaki J, Taniguchi K (2006) Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus. Proc Natl Acad Sci USA, 103, 4646-4651
9. Komoto S, Kugita M, Sasaki J, Taniguchi K (2008) Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4. J Virol, 82, 6753-6757
10. Burke B, Desselberger U (1996) Rotavirus pathogenicity. Virology, 218, 299-305. Review.
11. Ball JM, Tian P, Zeng CQY et al. (1996) Age dependent diarrhea induced by a rotaviral non-structural glycoprotein. Science, 272, 101-104
12. Seo NS, Zeng CQ, Hyser JM et al. (2008) Inaugural article: integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci USA, 105, 8811-8.
13. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L (2000) Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science, 287, 409-411
14. Blutt SE, Matson DO, Crawford SE et al. (2007) Rotavirus antigenemia in children is associated with viremia. PLoS Med, 4, e121.
15. Dormitzer PR (2005) Rotaviruses. In Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Elsevier, 1902-1913
16. Ramig RF (2007) Systemic rotavirus infection. Exp Rev Anti-Infect Ther, 5, 591-612.
17. Velazquez FR, Matson DO, Calva JJ et al. (1996) Rotavirus infection in infants as protection against subsequent infection. N Engl J Med, 355, 1022-1028
18. Franco MA, Angel J, Greenberg HB (2006) Immunity and correlates of protection for rota-virus vaccines. Vaccine, 24, 2718-2731 Review.
19. Burns JW, Siadat-Pajouh M, Krishnaney AA et al. (1996) Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science, 272, 104-107
20. Franco MA, Greenberg HB (1995) Role of B cells and cytotoxic T lymphocytes in clearance and immunity to rotavirus infection in mice. J Virol, 69, 7800-7806
21. Gouvea V, Glass RI, Woods P et al. (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol, 28, 276-282
22. Gentsch JR, Glass RI, Woods P et al. (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol, 30, 1365-1373
23. Simpson R, Aliyu S, Iturriza-Gomara M, Desselberger U, Gray J (2003) Infantile viral gastroenteritis: on the way to closing the diagnostic gap. J Med Virol, 70, 258-262
24. Desselberger U (1999) Rotavirus infections: guidelines for treatment and prevention. Drugs, 58, 447-452 Review.
25. Bass D (2003) Treatment of viral gastroenteritis. In Desselberger U, Gray J (eds) Viral Gastroenteritis, Amsterdam: Elsevier Science, 93-104.
26. Gentsch JR, Woods PA, Ramachandran M et al. (1996) Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis, 174, S30-6.
27. Desselberger U, Iturriza-Gó mara M, Gray J (2001) Rotavirus epidemiology and surveillance. Novartis Found Symp, 238, 125-147 Review.
28. Santos N, Hoshino Y (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol, 15, 29-56. Review.
29. Van Damme P, Giaquinto C, Maxwell M, Todd P, van der Wielen M, REVEAL Study Group (2007) Distribution of rotavirus genotypes in Europe 2004-2005: the REVEAL study. J Infect Dis, 195, S17-35.
30. Gleizes O, Desselberger U, Tatochenko V et al. (2006) Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus infections. Pediatr Infect Dis J, 25, S12-21. Review.
31. Hung T (1988) Rotavirus and adult diarrhoea. Adv Virus Res, 35, 193-218. Review.
32. Iturriza-Gó mara M, Desselberger U, Gray J (2003) Molecular epidemiology of rotaviruses: Genetic mechanisms associated with diversity. In Desselberger U, Gray J (eds) Viral Gastroenteritis. Amsterdam: Elsevier Science, 317-344 Review.
33. Iturriza-Gó mara M, Isherwood B, Desselberger U, Gray J (2001) Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol, 75, 3696-3705
34. Steyer A, Poljsak-Prijatelj M, Barlic-Maganja D, Marin J (2008) Human, porcine and bovine rotaviruses in Slovenia: evidence of interspecies transmission and genome reassort-ment. J Gen Virol, 89, 1690-1698
35. Glass RI, Parashar UD, Bresee JS et al. (2006) Rotavirus vaccines: current prospects and future challenges. Lancet, 368, 323-332
36. Glass RI, Parashar UD (2006). The promise of new rotavirus vaccines. N Engl J Med, 354, 75-77
37. Angel J, Franco MA, Greenberg HB (2007) Rotavirus vaccines: recent developments and future considerations. Nature Rev, 5, 529-539 Review.
38. Dennehy PH (2008) Rotavirus vaccines: an overview. Clin Microbiol Rev, 21, 198-208. Review.
39. Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices (ACIP) (1999) Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. MMWR Morb Mortal Wkly Rep 48, 1-22.
40. Murphy TV, Garguillo PM, Massoudi MS et al. (2001) Intussusception among infants given an oral rotavirus vaccine. N Engl J Med, 344, 564-572
41. Chang EJ, Zangwill KM, Lee H, Ward JI (2002) Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J, 21, 97-102.
42. Velazquez FR, Luna G, Cedillo R, Torres J, Munoz O (2004) Natural rotavirus infection is not associated with intussusception in Mexican children. Pediatr Infect Dis J, 23, S173-8.
43. Vesikari T, Matson DO, Dennehy P et al., Rotavirus Efficacy and Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med, 354, 23-33. (Pubitemid 43048948)
44. Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC) (2006) Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep, 55, 1-13.
45. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al. Human Rotavirus Vaccine Study Group (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med, 354, 11-22.
46. Vesikari T, Karvonen A, Prymula R et al. (2007) Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet, 370, 1757-1763
47. Vesikari T, Van Damme P, Giaquinto C et al. (2008) European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr, 46, 615-618
48. Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M, REVEAL Study Group (2007) Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis, 195, S4-S16. (Pubitemid 46649601)
49. Standaert B, Harlin O, Desselberger U (2008) The financial burden of rotavirus disease in four countries of the European Union. Pediatr Infect Dis J, 27, S20-S27.
50. Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R (2008) Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis, 8, 103.
51. Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI (2007) Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics, 119, 684-697
52. World Health Organization (2007) Rotavirus vaccines. WHO position paper. Wkly Epidemiol Rec, 82, 285-295
53. Desselberger U, Wolleswinkel-van den Bosch J, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T (2006) Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J, 25, S30-41.
54. Centers for Disease Control and Prevention (CDC) (2008) Delayed onset and diminished magnitude of rotavirus activity-United States November 2007-May 2008. MMWR Morb Mortal Wkly Rep, 57, 699-700.